Redcare Pharmacy Lifts 2026 Revenue Guidance on German Rx Momentum

Redcare Pharmacy N.V. (SAE1.F) raised its full-year 2026 revenue guidance on Monday, Sept. 28, 2026, its second upward revision this year, citing sustained strength in German prescription (Rx) revenue. The company said continued growth in its German Rx business drove the revised outlook. It did not disclose specific figures in the announcement. The upgrade marks the second time in 2026 that the online pharmacy has lifted its full-year revenue forecast, reflecting accelerating demand in its core prescription drug segment.